These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 8558205

  • 41. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
    Mizutani Y, Yoshida O.
    Cancer; 1994 Feb 01; 73(3):730-7. PubMed ID: 8299097
    [Abstract] [Full Text] [Related]

  • 42. Long-term buthionine-sulfoximine-mediated toxicity in cultured hepatoma cell lines.
    Dierickx PJ.
    Res Commun Chem Pathol Pharmacol; 1990 Mar 01; 67(3):423-6. PubMed ID: 2160706
    [Abstract] [Full Text] [Related]

  • 43. Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells.
    Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ.
    Biochem Pharmacol; 1999 Aug 15; 58(4):655-64. PubMed ID: 10413303
    [Abstract] [Full Text] [Related]

  • 44. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid.
    O'Dwyer PJ, LaCreta F, Nash S, Tinsley PW, Schilder R, Clapper ML, Tew KD, Panting L, Litwin S, Comis RL.
    Cancer Res; 1991 Nov 15; 51(22):6059-65. PubMed ID: 1933869
    [Abstract] [Full Text] [Related]

  • 45. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 15; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma.
    Tagde A, Singh H, Kang MH, Reynolds CP.
    Blood Cancer J; 2014 Jul 18; 4(7):e229. PubMed ID: 25036800
    [Abstract] [Full Text] [Related]

  • 49. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
    Hansson J, Edgren M, Ehrsson H, Ringborg U, Nilsson B.
    Cancer Res; 1988 Jan 01; 48(1):19-26. PubMed ID: 3334994
    [Abstract] [Full Text] [Related]

  • 50. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
    Chen G, Waxman DJ.
    Biochem Pharmacol; 1994 Mar 15; 47(6):1079-87. PubMed ID: 8147907
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.
    Robins HI, Rushing D, Kutz M, Tutsch KD, Tiggelaar CL, Paul D, Spriggs D, Kraemer C, Gillis W, Feierabend C, Arzoomanian RZ, Longo W, Alberti D, d'Oleire F, Qu RP, Wilding G, Stewart JA.
    J Clin Oncol; 1997 Jan 15; 15(1):158-64. PubMed ID: 8996137
    [Abstract] [Full Text] [Related]

  • 53. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
    Mitchell JB, Russo A, Biaglow JE, McPherson S.
    Radiat Res; 1983 Nov 15; 96(2):422-8. PubMed ID: 6647769
    [Abstract] [Full Text] [Related]

  • 54. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats.
    Coursin DB, Cihla HP.
    Am Rev Respir Dis; 1988 Dec 15; 138(6):1471-9. PubMed ID: 3202501
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
    Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR.
    Br J Cancer; 1991 Aug 15; 64(2):215-20. PubMed ID: 1892748
    [Abstract] [Full Text] [Related]

  • 57. The effect of glutathione (GSH) depletion in vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508.
    Kramer RA, Soble M, Howes AE, Montoya VP.
    Int J Radiat Oncol Biol Phys; 1989 May 15; 16(5):1325-9. PubMed ID: 2523885
    [Abstract] [Full Text] [Related]

  • 58. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC, Denekamp J, Minchinton AI.
    Radiat Res; 1985 Jun 15; 102(3):283-94. PubMed ID: 4070545
    [Abstract] [Full Text] [Related]

  • 59. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
    Kang YJ, Enger MD.
    Am J Physiol; 1992 Jan 15; 262(1 Pt 1):C122-7. PubMed ID: 1733228
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.